 |
CPhI South America
August 21, 2012–August 23, 2012
San Paulo, Brazil
Pharmaceutical Regulatory Summit
August 21, 2012–August 24, 2012
San Francisco, California
Pharma Extractables & Leachables
August 22, 2012–August 23, 2012
Mumbai, India
cGMP Quality Principles for Pharmaceuticals, Biopharmaceuticals, Biologics and Medical Devices
August 27, 2012–August 29, 2012
Los Angeles, California
3rd Annual Pharmacovigilance 2012
August 31, 2012
Mumbai, India 
|
|
|
 |
 
|
 |
AstraZeneca and Bristol-Myers Squibb Extend Diabetes Alliance
AstraZeneca has paid approximately $3.2 billion to extend its diabetes alliance with Bristol-Myers Squibb (BMS), following BMS’s recently completed acquisition of Amylin Pharmaceuticals.
Pfizer's Zoetis Subsidiary Files IPO
Zoetis, a subsidiary of Pfizer, filed a registration statement with the US Securities and Exchange Commission for a potential initial public offering of Class A common stock.
Advertisement:
Whether it's tracking incoming customer complaints, identifying nonconforming materials from production, or using CAPA to correct events within the system, having defined quality management processes in place can improve quality, reduce legal liability and make compliance a competitive advantage. Learn best practices to using Risk Assessment in a Quality Management System, and how to identify critical events, mitigate the risk, and prevent re-occurrence of these events.  Read More |
Elan to Spin Off Discovery Sciences
Elan Corporation announced plans to spin off its discovery unit and Neotope Biosciences division to create an independent entity focused on R&D.
Advertisement:
Ropack provides solid dose packaging services to leading pharmaceutical and healthcare companies. Operating in 250,000 square feet, Ropack is equipped for humidity- and temperature-sensitive production and packaging of stick-packs. Other services include blister, bottle and pouch, powder blending and encapsulation and in-country clinical trial packaging and distribution management. Ropack has the capacity, technology and resources to grow your business. Contact:paul.dupont@ropack.com
 Read More |
PhRMA Research Awards Focus on Alzheimer's Disease
On Sept. 12, 2012, PhRMA is cohosting a brand new national awards program in Washington, DC, to honor individuals and organizations that have contributed significantly to the fight against Alzheimer’s Disease.
|
|
 Capsule filler with multiple dosing units is designed for small runs
MG America’s FlexaLAB capsule filler, which can produce up to 3000 capsules per hour, is designed for research and development, clinical trials, and small-batch production. The FlexaLAB can function with either continuous or intermittent motion. Installing multiple dosing units allows the FlexaLAB to manufacture capsules with combinations of products. The machine can fill powders, pellets, microtablets, tablets, liquids, and certain low-dosage powder inhalants and can perform capsule-into-capsule functions. The machine includes a touch-screen panel and PLC for machine-functions control. Machine speed can be adjusted from the monitor.
|
|
|
 |
|
Bristol-Myers Squibb (BMS) has successfully completed its tender offer of Amylin Pharmaceuticals through its wholly owned subsidiary, B&R Acquisition Company, for all outstanding shares of common stock of Amylin at a purchase price of approximately $31 per share. Read More
Pfizer and AstraZeneca have entered into an agreement for the OTC rights for Nexium (esomeprazole magnesium), for treating gastroesophageal reflux disease. Under the agreement, Pfizer will acquire the exclusive global rights to market Nexium for the approved OTC indications in the US, Europe, and the rest of the world. Under the agreement, Pfizer will make an upfront payment of $250 million to AstraZeneca, and AstraZeneca is eligible to receive milestone and royalty payments based on product launches and sales. Read More
The CRO Quintiles has acquired Expression Analysis, a provider of genomics testing and analysis to biopharmaceutical, academic, government, and nonprofit clients. Read More
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers. Read More
Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to ptpress@advanstar.com |
|
|
|
 |
| Measuring Growth in Big Pharma's Manufacturing Investment |
by: Patricia Van Arnum
Pharmaceutical Technology’s annual manufacturing investment update shows slight gains in biopharmaceutical manufacturing and emerging markets and continued restructuring of supply networks.
|
Coming soon: Pharm Tech’s September issue will explore asymmetric synthesis and chiral chemistry. |
|
|
|
Know Before You Go—2012 Conference Previews
Visit our Show & Exhibition Gateway 2012 to see which companies are exhibiting at upcoming industry conferences.
Find company backgrounds, new product releases, booth materials, and more.
PharmTech's online
Gateway is your guide to the season's leading shows.
|
|
|
|
|
|
